These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 30717062)

  • 1. Wound healing complications after revascularization for moyamoya vasculopathy with reference to different skin incisions.
    Acker G; Schlinkmann N; Fekonja L; Grünwald L; Hardt J; Czabanka M; Vajkoczy P
    Neurosurg Focus; 2019 Feb; 46(2):E12. PubMed ID: 30717062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.
    Bot GM; Burkhardt JK; Gupta N; Lawton MT
    J Neurosurg Pediatr; 2019 Feb; 23(2):198-203. PubMed ID: 30497164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operative wound-related complications after cranial revascularization surgeries.
    Takanari K; Araki Y; Okamoto S; Sato H; Yagi S; Toriyama K; Yokoyama K; Murotani K; Matsui S; Wakabayashi T; Kamei Y
    J Neurosurg; 2015 Nov; 123(5):1145-50. PubMed ID: 26140494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
    Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
    World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral acute vascular occlusion following revascularization surgery for moyamoya disease.
    Sussman ES; Madhugiri V; Teo M; Nielsen TH; Furtado SV; Pendharkar AV; Ho AL; Esparza R; Azad TD; Zhang M; Steinberg GK
    J Neurosurg; 2019 Dec; 131(6):1702-1708. PubMed ID: 30554188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2020 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater ultrasonographic changes in pediatric moyamoya patients compared with adults after indirect revascularization surgeries.
    Yeh SJ; Tang SC; Tsai LK; Lee CW; Chen YF; Liu HM; Yang SH; Hsieh YL; Kuo MF; Jeng JS
    J Neurosurg Pediatr; 2018 Dec; 22(6):663-671. PubMed ID: 30168733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of moyamoya disease in pediatric patients--comparison between the results of indirect and direct revascularization procedures.
    Matsushima T; Inoue T; Suzuki SO; Fujii K; Fukui M; Hasuo K
    Neurosurgery; 1992 Sep; 31(3):401-5. PubMed ID: 1407421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery.
    Czabanka M; Boschi A; Acker G; Peña-Tapia P; Schubert GA; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2016 Oct; 158(10):1895-900. PubMed ID: 27573349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "STA-MCA bypass with encephalo-duro-myo-synangiosis combined with bifrontal encephalo-duro-periosteal-synangiosis" as a one-staged revascularization strategy for pediatric moyamoya vasculopathy.
    Esposito G; Kronenburg A; Fierstra J; Braun KP; Klijn CJ; van der Zwan A; Regli L
    Childs Nerv Syst; 2015 May; 31(5):765-72. PubMed ID: 25722049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical results in pediatric moyamoya disease: angiographic revascularization and the clinical results.
    Kim DS; Kang SG; Yoo DS; Huh PW; Cho KS; Park CK
    Clin Neurol Neurosurg; 2007 Feb; 109(2):125-31. PubMed ID: 16872739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative neovascularization, cerebral hemodynamics, and clinical prognosis between combined and indirect bypass revascularization procedures in hemorrhagic moyamoya disease.
    Sun J; Li ZY; Chen C; Ling C; Li H; Wang H
    Clin Neurol Neurosurg; 2021 Sep; 208():106869. PubMed ID: 34419781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease.
    Czabanka M; Peña-Tapia P; Scharf J; Schubert GA; Münch E; Horn P; Schmiedek P; Vajkoczy P
    Cerebrovasc Dis; 2011; 32(4):361-9. PubMed ID: 21921600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial temporal artery lengthening technique to prevent postoperative wound complications in direct revascularization to the anterior cerebral artery for Moyamoya disease.
    Tsunoda S; Inoue T; Segawa M; Kawashima M; Akabane A; Saito N
    Acta Neurochir (Wien); 2022 Jul; 164(7):1845-1854. PubMed ID: 35304649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease.
    Bang JS; Kwon OK; Kim JE; Kang HS; Park H; Cho SY; Oh CW
    Neurosurgery; 2012 Mar; 70(3):625-32; discussion 632-3. PubMed ID: 21866061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.